Telerehabilitation versus face-to-face physical therapy for middle-aged patients with degenerative meniscal tear in China: a non-inferiority randomized controlled trial

远程康复与面对面物理治疗对中国中年退行性半月板撕裂患者的疗效比较:一项非劣效性随机对照试验

阅读:1

Abstract

OBJECTIVE: This study aimed to compare the effectiveness of telerehabilitation to traditional face- to-face physical therapy for patients with degenerative meniscal tears in Shanghai, China. DESIGN: A two-arm, single-blinded, randomized controlled trial was conducted across two hospitals in Shanghai, China Subjects/Patients: Participants with clinically diagnosed degenerative meniscal tears were randomly assigned to either the telerehabilitation group or the face-to-face physical therapy group. METHODS: Both groups underwent a 12-week intervention. Participants in telerehabilitation group used a digital platform for remote physical therapy, while participants in physical therapy group received traditional clinic-based rehabilitation. A predefined non-inferiority margin of 10 points on the Knee Injury and Osteoarthritis Outcome Score (KOOS) was applied to determine clinical equivalence between the interventions. RESULTS: Both groups demonstrated significant improvements in knee function and quality of life, with no significant differences in the KOOS, SF-36, or functional tests at any time point (p > 0.05). Both groups had high adherence rates, with no significant differences in exercise completion or satisfaction scores. The TELE group had a significantly lower total cost compared to the PT group (p < 0.001), demonstrating greater cost-effectiveness. CONCLUSION: Telerehabilitation was found to be clinically non-inferior to face-to-face physical therapy for improving knee function, pain, and quality of life in patients with degenerative meniscal tears. It offered significant cost savings, making it a cost-effective alternative to traditional in-person rehabilitation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。